NeOnc Reports Improved Interim NEO100 Phase 2a Response Rate
at www.tipranks.com (Wed, 18-Nov 11:58 AM)
Roth MKM Reaffirms Their Buy Rating on NeOnc Technologies Holdings, Inc. (NTHI)
at www.tipranks.com (Wed, 18-Nov 11:15 AM)
NTHI Highlights Phase 2a Signal for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
Market Chameleon (Mon, 21-Sep 11:40 AM)
NTHI Redeems All Series A Preferred Shares, Removing a Discounted Conversion Overhang
Market Chameleon (Fri, 18-Sep 10:06 AM)